A structural investigation on the isoxazole scaffold led to the discovery of 3,4-isoxazolediamide compounds endowed with potent Hsp90 inhibitory properties. We have found that compounds possessing a nitrogen atom directly attached to the C-4 heterocycle ring possess in vitro Hsp90 inhibitory properties at least comparable to those of the structurally related 4,S-diarylisoxazole derivatives. A group of compounds from this series of diamides combine potent binding affinity and cell growth inhibitory activity in both series of alkyl- and aryl- or heteroarylarnides, with IC50 in the low nanomolar range. The 3,4-isoxazolediamides were also very effective in causing dramatic depletion of the examined client proteins and, as expected for the Hsp90...
Hsp90 is considered an interesting therapeutic target for anticancer drug development. Here we descr...
The molecular chaperone heat shock protein 90 (HSP90) is a promising target for cancer therapy, as i...
A potential therapeutic strategy for targeting cancer that has gained much interest is the inhibitio...
A structural investigation on the isoxazole scaffold led to the discovery of 3,4-isoxazolediamide co...
A structural investigation on the isoxazole scaffold led to the discovery of 3,4-isoxazolediamide co...
A structural investigation on the isoxazole scaffold led to the discovery of 3,4-isoxazolediamide co...
A series of 3-aryl-naphtho[2,3-d]isoxazole-4,9-diones and some of their 6-aza analogues were synthes...
none19noA series of 3-aryl-naphtho[2,3-d]isoxazole-4,9-diones and some of their 6-aza analogues were...
A series of 3-aryl-naphtho[2,3-d]isoxazole-4,9-diones and some of their 6-aza analogues were synthes...
Heat shock protein 90 (Hsp90) is a molecular chaperone that is responsible for activating many signa...
Although the heat shock protein 90 (HSP90) inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG)...
Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential chemothera...
Background: Heat shock protein 90 (HSP90) is a well-known target for cancer therapy. In a previous w...
Heat shock protein 90 (Hsp90) is a molecular chaperone that is responsible for activating many signa...
A potential therapeutic strategy for targeting cancer that has gained much interest is the inhibitio...
Hsp90 is considered an interesting therapeutic target for anticancer drug development. Here we descr...
The molecular chaperone heat shock protein 90 (HSP90) is a promising target for cancer therapy, as i...
A potential therapeutic strategy for targeting cancer that has gained much interest is the inhibitio...
A structural investigation on the isoxazole scaffold led to the discovery of 3,4-isoxazolediamide co...
A structural investigation on the isoxazole scaffold led to the discovery of 3,4-isoxazolediamide co...
A structural investigation on the isoxazole scaffold led to the discovery of 3,4-isoxazolediamide co...
A series of 3-aryl-naphtho[2,3-d]isoxazole-4,9-diones and some of their 6-aza analogues were synthes...
none19noA series of 3-aryl-naphtho[2,3-d]isoxazole-4,9-diones and some of their 6-aza analogues were...
A series of 3-aryl-naphtho[2,3-d]isoxazole-4,9-diones and some of their 6-aza analogues were synthes...
Heat shock protein 90 (Hsp90) is a molecular chaperone that is responsible for activating many signa...
Although the heat shock protein 90 (HSP90) inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG)...
Inhibitors of the Hsp90 molecular chaperone are showing considerable promise as potential chemothera...
Background: Heat shock protein 90 (HSP90) is a well-known target for cancer therapy. In a previous w...
Heat shock protein 90 (Hsp90) is a molecular chaperone that is responsible for activating many signa...
A potential therapeutic strategy for targeting cancer that has gained much interest is the inhibitio...
Hsp90 is considered an interesting therapeutic target for anticancer drug development. Here we descr...
The molecular chaperone heat shock protein 90 (HSP90) is a promising target for cancer therapy, as i...
A potential therapeutic strategy for targeting cancer that has gained much interest is the inhibitio...